HALO Macrodissection Solutions Brochure
Learn more about the automated workflow and benefits of HALO Macrodissection Solutions
HALO Macrodissection Solutions Brochure Read More »
Clinical
KLAS Recognition as a Catalyst for What Comes Next
We are proud to mark a significant milestone: HALO AP® earned the highest overall customer rating in the 2026 KLAS Global Software report for digital pathology. Because KLAS distinction is driven entirely by direct customer feedback, this recognition reflects the real-world performance, reliability, and impact of our platform in daily pathology practice.
KLAS Recognition as a Catalyst for What Comes Next Read More »
Indica Labs Sets New Standard for Molecular Testing in Breast Cancer with Expansion of AI Macrodissection Portfolio
Albuquerque, NM, February 10, 2025 – Indica Labs, the world’s leading provider of AI-powered digital pathology solutions, today announced the expansion of its macrodissection portfolio with the launch of Breast Macrodissect AI . The suite now includes advanced algorithms for non-small cell lung cancer (NSCLC), colorectal cancer (CRC), and breast cancer, with prostate cancer planned for release in early 2026.
Indica Labs Receives FDA Clearance for Enterprise Digital Pathology Platform with Industry Leading DICOM-Compatible Aperio Scanner from Leica Biosystems
ALBUQUERQUE, NM, and VISTA, CA, December 3, 2025 – Indica Labs, the global leader of AI-powered digital pathology, and Leica Biosystems, a global leader in anatomic and digital pathology solutions, announced today that the Food and Drug Administration (FDA) has issued a 510(k) clearance for the enterprise digital pathology platform HALO AP Dx in conjunction with Leica Biosystems Aperio GT 450 DX Scanner for in-vitro diagnostic use.
HALO AP® and Breast IHC AI at MAPMG
Learn more about how MidAtlantic Permanente Medical Group (MAPMG) used Breast IHC AI deployed in HALO AP® to standardize prognostic scores in newly diagnosed breast cancers and increase diagnostic efficiency of first reads.
HALO AP® and Breast IHC AI at MAPMG Read More »
An Automated Clinical Workflow Integrating an AI-driven PD-L1 22C3 Scoring Algorithm into a Browser-Based Digital Pathology Solution
Discover how Guardant Health has seamlessly integrated Lunit SCOPE PD-L1 with HALO AP® for enhanced PD-L1 analysis.
Lunit SCOPE PD-L1 and HALO AP® Application Note
Download this Application Note to learn more about how Lunit SCOPE PD-L1 was integrated into the HALO AP® digital pathology solution at Guardant Health.
Lunit SCOPE PD-L1 and HALO AP® Application Note Read More »
Lung PD-L1 AI Brochure
Learn more about the automated workflow and benefits of utilizing Lung PD-L1 AI.
Lung PD-L1 AI Brochure Read More »
Novel CE-IVD clinical workflow for analysis of prostate cancer core needle biopsies
Learn more about Indica Labs’ novel CE-IVD certified deep learning clinical workflow for prostate cancer grading.
Novel CE-IVD clinical workflow for analysis of prostate cancer core needle biopsies Read More »
An Automated Deep Learning Artifact Detection Tool for Quality Control of Whole-Slide Digital Pathology Images
Explore SlideQC: an AI-based tool which identifies pre-analytic processing errors in whole-slide images for quality control in digital pathology laboratories.